📞Call us
+91 80629 16290
Aarti Drugs Ltd.
₹421.6
15.9 (3.9%)
AARTIDRUGS Share Price
As on July 15, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 3,827 Cr
P/E Ratio22.88
Dividend Yield0.02 %
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open408
High427.9
NSE SymbolAARTIDRUGS
Close421.6
Low405.5
BSE Symbol524348
Previous Years High/Low
1 Year High564.05
3 Year High645.75
5 Year High735
1 Year Low318.95
3 Year Low312
5 Year Low312
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 403.03 | Bullish |
| 10-DMA | 394.19 | Bullish |
| 20-DMA | 383.69 | Bullish |
| 50-DMA | 381.11 | Bullish |
| 100-DMA | 369.95 | Bullish |
| 200-DMA | 403 | Bullish |
Historical Performance
1 Year
-20.5%
3 Years
-15.3%
5 Years
-41.2%
10 Years
239.9%
Shareholding Pattern
%
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
| Net Sales | 23,870 | 25,286 | 27,160 | 24,886 | 21,548 |
| Total Expenditure | 20,968 | 22,077 | 24,066 | 21,560 | 17,144 |
| Other Income | 164 | 40 | 22 | 113 | 45 |
| Operating Profit | 3,066 | 3,249 | 3,116 | 3,439 | 4,449 |
| Interest | 390 | 379 | 371 | 239 | 262 |
| Depreciation | 558 | 514 | 503 | 500 | 499 |
| Profit Before Tax | 2,118 | 2,355 | 2,242 | 2,700 | 3,690 |
| Consolidated Net Profit | 1,682 | 1,714 | 1,663 | 2,050 | 2,804 |
| Adjusted EPS | 18 | 19 | 18 | 22 | 30 |
Compounded Sales Growth
10 Years:16.8
5 Years:5.7
3 Years:-0.8
TTM:-1.1
Compounded Profit Growth
10 Years:16.8
5 Years:3.5
3 Years:-3.9
TTM:-0.4
Stock Price CAGR
10 Years:13
5 Years:-10.4
3 Years:-5.4
TTM:-19
Return on Equity
10 Years:7.1
5 Years:30.1
3 Years:18
last year:18.4
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
| Share Capital | 913 | 919 | 926 | 926 | 932 |
| Total Reserves | 12,777 | 11,896 | 10,998 | 9,438 | 8,202 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 3,684 | 3,549 | 2,793 | 2,316 | 2,572 |
| Other Current Liabilities | 1,447 | 1,512 | 1,001 | 1,113 | 1,054 |
| Short Term Borrowings | 2,718 | 2,147 | 3,605 | 3,563 | 1,572 |
| Total Liabilities | 25,747 | 24,324 | 24,214 | 22,080 | 17,660 |
| Capital Work in Progress | 2,741 | 2,252 | 1,868 | 767 | 193 |
| Long Term Loans & Advances | 176 | 197 | 242 | 284 | 73 |
| Currents Investments | --- | --- | --- | --- | --- |
| Short Term Loans and Advances | 1,028 | 1,176 | 987 | 945 | 743 |
| Total Current Assets | 13,384 | 13,207 | 14,918 | 13,934 | 10,568 |
| Total Assets | 25,747 | 24,324 | 24,214 | 22,080 | 17,660 |
| Adjusted Book Value | 150 | 139 | 129 | 112 | 98 |
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a moderate PE of 22.88, suggesting fair valuation relative to earnings.
- Over the last three years, the stock delivered a weak 3-year price CAGR of -5.9%, indicating poor shareholder returns.
- The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
- In the last financial year, the company reported an EBITDA of ₹3066 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹23870 million, indicating a large and established business.
Investment Calculator
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 810379.6
No. of Shares: 1922 (Approx)
Performance:-19%
-189620.4
NIFTY Performance: -4.5%
1 day Top Gainers
| Symbol | Change% |
|---|---|
| NUVOCO | 377.25(11%) |
| AEGISLOG | 1321.1(8%) |
| ATHERENERG | 1296.4(8%) |
| LTTS | 3508.3(7%) |
| INOXINDIA | 1964.4(6%) |
1 Day Top Losers
| Symbol | Change% |
|---|---|
| PATANJALI | 347.9(-15%) |
| TATAELXSI | 3520.4(-5%) |
| DBREALTY | 116.87(-5%) |
| ADANIPOWER | 218.97(-3%) |
| ADANIGREEN | 1555.4(-3%) |
| GODIGIT | 298.65(-3%) |
| JSWINFRA | 337.35(-3%) |
| ZENSARTECH | 513.1(-3%) |
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
